4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001788542-23-000004
Chief Commercial Officer sold 1,078 shares at an average $12.55 ($13,531)
From the SEC's structured data for this filing
Trades in this filing
Mottiwala Aziz · Chief Commercial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-03-21 | Sale : show line 1 in the form | −349 | $12.89 | $4,499 | 53,558 | D |
| 2023-03-22 | Sale : show line 2 in the form | −357 | $12.64 | $4,512 | 53,201 | D |
| 2023-03-23 | Sale : show line 3 in the form | −372 | $12.15 | $4,520 | 52,829 | D |
| Open-market sales · 1,078 sh · avg $12.55 · $13,531 | ||||||
Loading xslF345X04/wf-form4_167961515955541.xml…